Response to mepolizumab treatment in patients with severe eosinophilic asthma and atopic phenotypes
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Journal of asthma and allergy. - 14 (2021) , 675-683, ISSN: 1178-6965
- Ereignis
-
Veröffentlichung
- (wo)
-
Freiburg
- (wer)
-
Universität
- (wann)
-
2021
- Urheber
-
Prazma, Charlene M
Idzko, Marco
Douglass, Jo Anne
Bourdin, Arnaud
Mallett, Stephen
Albers, Frank C
Yancey, Steven W
- DOI
-
10.2147/JAA.S298559
- URN
-
urn:nbn:de:bsz:25-freidok-2193610
- Rechteinformation
-
Kein Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Prazma, Charlene M
- Idzko, Marco
- Douglass, Jo Anne
- Bourdin, Arnaud
- Mallett, Stephen
- Albers, Frank C
- Yancey, Steven W
- Universität
Entstanden
- 2021
Ähnliche Objekte (12)
Eosinophilic bioactivities in severe asthma
Prevalence of eosinophilic, atopic, and overlap phenotypes among patients with severe asthma in Saudi Arabia: a cross-sectional study
Emerging Biological Therapies in Severe Eosinophilic Asthma
Rapid effect of benralizumab in exacerbation of severe eosinophilic asthma associated with eosinophilic granulomatosis with polyangiitis
Efficacy of add-on mepolizumab in adolescents with severe eosinophilic asthma
Effective use of dupilumab for eosinophilic gastritis concomitant with severe asthma
Efficacy of mepolizumab for patients with severe asthma and eosinophilic chronic rhinosinusitis
Biological function of eosinophil extracellular traps in patients with severe eosinophilic asthma
Safety of Eosinophil-Depleting Therapy for Severe, Eosinophilic Asthma: Focus on Benralizumab
Airway autoimmune responses in severe eosinophilic asthma following low-dose Mepolizumab therapy
Severe asthma with viral infection can develop into eosinophilic granulomatosis with polyangiitis
Atopic dermatitis phenotypes in childhood
Eosinophilic bioactivities in severe asthma
Prevalence of eosinophilic, atopic, and overlap phenotypes among patients with severe asthma in Saudi Arabia: a cross-sectional study
Emerging Biological Therapies in Severe Eosinophilic Asthma
Rapid effect of benralizumab in exacerbation of severe eosinophilic asthma associated with eosinophilic granulomatosis with polyangiitis
Efficacy of add-on mepolizumab in adolescents with severe eosinophilic asthma
Effective use of dupilumab for eosinophilic gastritis concomitant with severe asthma
Efficacy of mepolizumab for patients with severe asthma and eosinophilic chronic rhinosinusitis
Biological function of eosinophil extracellular traps in patients with severe eosinophilic asthma
Safety of Eosinophil-Depleting Therapy for Severe, Eosinophilic Asthma: Focus on Benralizumab
Airway autoimmune responses in severe eosinophilic asthma following low-dose Mepolizumab therapy
Severe asthma with viral infection can develop into eosinophilic granulomatosis with polyangiitis
Atopic dermatitis phenotypes in childhood
Eosinophilic bioactivities in severe asthma
Prevalence of eosinophilic, atopic, and overlap phenotypes among patients with severe asthma in Saudi Arabia: a cross-sectional study
Emerging Biological Therapies in Severe Eosinophilic Asthma
Rapid effect of benralizumab in exacerbation of severe eosinophilic asthma associated with eosinophilic granulomatosis with polyangiitis
Efficacy of add-on mepolizumab in adolescents with severe eosinophilic asthma
Effective use of dupilumab for eosinophilic gastritis concomitant with severe asthma
Efficacy of mepolizumab for patients with severe asthma and eosinophilic chronic rhinosinusitis
Biological function of eosinophil extracellular traps in patients with severe eosinophilic asthma
Safety of Eosinophil-Depleting Therapy for Severe, Eosinophilic Asthma: Focus on Benralizumab
Airway autoimmune responses in severe eosinophilic asthma following low-dose Mepolizumab therapy
Severe asthma with viral infection can develop into eosinophilic granulomatosis with polyangiitis